Sign In
Buy CTSO
$0.361
+0.0108 (+3.08%)
At Close: Jul 31, 2026
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
07:00am, Tuesday, 11'th Nov 2025
PRINCETON, N.J. , Nov. 11, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
07:00am, Thursday, 30'th Oct 2025
PRINCETON, N.J. , Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
PRINCETON, N.J. , Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
07:00am, Monday, 29'th Sep 2025
PRINCETON, N.J. , Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using
CytoSorbents Provides DrugSorb-ATR Regulatory Update
07:00am, Tuesday, 16'th Sep 2025
PRINCETON, N.J. , Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usi
PRINCETON, N.J. , Sept. 8, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
07:00am, Friday, 05'th Sep 2025
PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
07:00am, Wednesday, 20'th Aug 2025
FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization PRINCETON, N.J. , Aug. 20, 2025 /PRNew
Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript
01:22pm, Friday, 08'th Aug 2025
Cytosorbents Corporation (NASDAQ:CTSO ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Peter J. Mariani - Chief Financial Officer Phillip P.
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
04:00pm, Thursday, 07'th Aug 2025
PRINCETON, N.J. , Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
CytoSorbents Leads a New Era in Sepsis Treatment
07:00am, Thursday, 31'st Jul 2025
CytoSorbents highlights the vital and evolving role of CytoSorb® in the treatment of sepsis and septic shock ahead of its World Sepsis Day Global Webinar on September 10 th PRINCETON, N.J. , July 31,
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
07:00am, Tuesday, 29'th Jul 2025
PRINCETON, N.J. , July 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
07:00am, Wednesday, 02'nd Jul 2025
PRINCETON, N.J. , July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardia
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
07:00am, Tuesday, 24'th Jun 2025
PRINCETON, N.J. , June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using
CytoSorbents to Participate at the Jefferies Global Healthcare Conference
07:00am, Thursday, 29'th May 2025
PRINCETON, N.J. , May 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using bl
